(Q45303684)

11 December 2017

How do neurons die in neurodegenerative diseases? (English)

1 reference

11 December 2017

1 reference

Kanazawa I

1

1 reference

11 December 2017

1 August 2001

1 reference

Trends in Molecular Medicine

11 December 2017

1 reference

11 December 2017

7

1 reference

11 December 2017

8

1 reference

11 December 2017

339-344

1 reference

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Tau protein pathology in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Trinucleotide repeat length instability and age of onset in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Changes in shapes of surviving motor neurons in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Nuclear membrane indentations in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Advanced glycation endproducts in ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Energetics in the pathogenesis of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Oxidative stress in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Glutamate neurotoxicity and diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Oxidative stress: its role in the pathogenesis of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Parkinson disease gene therapy moves toward the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902017-2

7 January 2021

10.1016/S1471-4914(01)02017-2

Identifiers

DOI

1 reference

11 December 2017

1 reference

PubMed ID

11516993